Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iva Gunnarsson

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Clinical Rheumatology|June 27, 2023
Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitisAgneta Zickert, Marija Ratković Janković, Vivianne Malmström, et al.
Rheumatology (Oxford, England)|June 25, 2010
Women's experience of SLE-related fatigue: a focus group interview studySusanne Pettersson, Sonia Möller, Elisabet Svenungsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2011
Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathySigrid Lundberg, Joachim Lundahl, Iva Gunnarsson, et al.
Rheumatology (Oxford, England)|August 12, 2025
Exploration of health-related quality of life, anxiety, and depression in antineutrophil cytoplasmic antibody-associated vasculitisAnnika Granath, Sara Brolin, Karuna Dahlberg, et al.
Kidney International Reports|February 12, 2020
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous NephropathyCornelia Dähnrich, Sandra Saschenbrecker, Iva Gunnarsson, et al.
BMC Immunology|April 19, 2015
IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatmentAgneta Zickert, Petra Amoudruz, Yvonne Sundström, et al.
Frontiers in Immunology|June 18, 2025
Role of interleukin-16 in human diseases: a novel potential therapeutic targetTimothy B Niewold, Julia S Lehman, Iva Gunnarsson, et al.
Lupus Science & Medicine|September 16, 2021
Infection hospitalisation in systemic lupus in SwedenJulia F Simard, Marios Rossides, Iva Gunnarsson, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2023
The expression of antibodies to Z-DNA in the blood of patients with systemic lupus erythematosus: Relationship to autoantibodies to B-DNADiane M Spencer, Elisabet Svenungsson, Iva Gunnarsson, et al.
Lupus Science & Medicine|December 10, 2016
Interferon (IFN)-λ is a potential mediator in lupus nephritisAgneta Zickert, Vilija Oke, Ioannis Parodis, et al.
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Clinical Rheumatology|June 27, 2023
Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitisAgneta Zickert, Marija Ratković Janković, Vivianne Malmström, et al.
Rheumatology (Oxford, England)|June 25, 2010
Women's experience of SLE-related fatigue: a focus group interview studySusanne Pettersson, Sonia Möller, Elisabet Svenungsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2011
Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathySigrid Lundberg, Joachim Lundahl, Iva Gunnarsson, et al.
Rheumatology (Oxford, England)|August 12, 2025
Exploration of health-related quality of life, anxiety, and depression in antineutrophil cytoplasmic antibody-associated vasculitisAnnika Granath, Sara Brolin, Karuna Dahlberg, et al.
Kidney International Reports|February 12, 2020
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous NephropathyCornelia Dähnrich, Sandra Saschenbrecker, Iva Gunnarsson, et al.
BMC Immunology|April 19, 2015
IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatmentAgneta Zickert, Petra Amoudruz, Yvonne Sundström, et al.
Frontiers in Immunology|June 18, 2025
Role of interleukin-16 in human diseases: a novel potential therapeutic targetTimothy B Niewold, Julia S Lehman, Iva Gunnarsson, et al.
Lupus Science & Medicine|September 16, 2021
Infection hospitalisation in systemic lupus in SwedenJulia F Simard, Marios Rossides, Iva Gunnarsson, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2023
The expression of antibodies to Z-DNA in the blood of patients with systemic lupus erythematosus: Relationship to autoantibodies to B-DNADiane M Spencer, Elisabet Svenungsson, Iva Gunnarsson, et al.
Lupus Science & Medicine|December 10, 2016
Interferon (IFN)-λ is a potential mediator in lupus nephritisAgneta Zickert, Vilija Oke, Ioannis Parodis, et al.
Pageof 20